CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 34,208 shares (grant or award)
- 4 Open-market sale CEO sold 5,483 shares at $18.18 ($99,691)
- 4 Open-market sale President sold 2,865 shares at $18.18 ($52,091)
- 4 Open-market sale EVP,General Counsel, Secretary sold 894 shares at $18.18 ($16,255)
- 4 Open-market sale EVP, COO, Head of Commercial sold 552 shares at $18.18 ($10,036)
- 4 Open-market sale Principal Accounting Officer sold 1,025 shares at $27.05 ($27,726)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Principal Accounting Officer sold 359 shares at $23.80 ($8,544)
- 4 Open-market sale EVP, COO, Head of Commercial sold 472 shares at $23.80 ($11,234)
- 4 Open-market sale Chief Financial Officer sold 553 shares at $23.80 ($13,161)
- 4 Open-market sale EVP & General Counsel sold 782 shares at $23.80 ($18,612)
- 4 Open-market sale President sold 1,501 shares at $23.80 ($35,724)
Page 9 of 35 · 686 filings